HER2 Support Group Forums - View Single Post - Indication of major added benefit for trastuzumab emtansine in metastatic breast canc

News · 04-10-2014, 02:10 AM

Added benefit not proven in three further subpopulations because appropriate comparator therapies were not implementedThe antibody-drug conjugate trastuzumab emtansine (trade name: Kadcyla) has...

More...

04-10-2014, 02:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,153	Indication of major added benefit for trastuzumab emtansine in metastatic breast canc Added benefit not proven in three further subpopulations because appropriate comparator therapies were not implementedThe antibody-drug conjugate trastuzumab emtansine (trade name: Kadcyla) has... More...